PROGNOSTIC FACTORS FROM A RANDOMIZED CLINICAL-TRIAL IN RESECTED LUNG-CANCER

被引:4
作者
CHASTANG, C
LEBEAU, B
CHARPAK, Y
DECROIX, G
机构
关键词
D O I
10.1002/sim.4780040306
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:279 / 285
页数:7
相关论文
共 10 条
[1]  
BOUCKENAEREWOJCIK D, 1982, B CANCER, V69, P468
[2]  
DECROIX G, 1984, CANCER, V53, P906, DOI 10.1002/1097-0142(19840215)53:4<906::AID-CNCR2820530415>3.0.CO
[3]  
2-H
[4]  
DELBRUCK H, 1982, TUMORDIAGN THER, V3, P18
[5]   PLANNING SIZE AND DURATION OF A CLINICAL TRIAL STUDYING TIME TO SOME CRITICAL EVENT [J].
GEORGE, SL ;
DESU, MM .
JOURNAL OF CHRONIC DISEASES, 1974, 27 (1-2) :15-24
[6]  
KNIKER WT, 1979, ANN ALLERGY, V43, P73
[7]  
LANG JM, 1980, BIOMED EXPRESS, V33, P62
[8]  
TEMECK BK, 1984, CANCER, V53, P1405, DOI 10.1002/1097-0142(19840315)53:6<1405::AID-CNCR2820530631>3.0.CO
[9]  
2-N
[10]  
1979, STAGING LUNG CANCER